Skip to content
Parakho

Aarti Pharmalabs Ltd

NSE AARTIPHARMBSE 543748aartipharmalabs.com

Q1 FY27, unaudited

Revenue
₹535.80 Cr
Profit after tax
₹76.14 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations535.80+38.74%1,819.44
Other income0.45−71.63%9.75
Total income536.25+38.28%1,829.19
Employee benefit expense50.32+21.98%173.09
Finance costs12.88+89.48%46.90
Depreciation & amortisation30.03+31.75%104.34
Total expenses442.59+38.08%1,601.47
Profit before tax93.65+39.26%224.92
Tax expense24.92+56.19%58.21
Profit after tax76.14+53.82%174.71
Total comprehensive income77.76+54.08%168.47
Earnings per share
Earnings per share, basic₹8.40₹19.27
Earnings per share, diluted₹8.39₹19.25

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Aarti Pharmalabs reported Q4 FY2026 standalone revenue of Rs.580 Crores, up 9% year-on-year, while full year FY2026 revenue was Rs.1798 Crores against Rs.1771 Crores in FY2025. EBITDA and profit after tax declined both for the quarter and the full year compared to the previous year, with management citing a net foreign exchange loss and cost pressures from the West Asia conflict. Management discussed segment performance across Xanthine derivatives, API/Intermediates and CDMO/CMO, and outlined capex plans and capacity expansions at Tarapur and Atali for the coming year.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 39 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 18 Aug 2026.